• Find an Expert
  • Search iconSearch
  • Menu
  • Help
  • Report an issue

ENHANCING IMMUNE CELL TRAFFICKING TO TUMOURS TO IMPROVE THE THERAPY OF BREAST CANCER

Grant number: IIRS-19-016 | Funding period: 2019 - 2023

Active

Related publications (1)

Scholarly works icon

Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade

Imran G House, Peter Savas, Junyun Lai, Amanda XY Chen, Amanda J Oliver, Zhi L Teo, Kirsten L Todd, Melissa A Henderson, Lauren Giuffrida, Emma V Petley, Kevin Sek, Sherly Mardiana, Tuba N Gide, Camelia Quek, Richard A Scolyer, Georgina V Long, James S Wilmott, Sherene Loi, Phillip K Darcy, Paul A Beavis

2020-01-15

PURPOSE: Response rates to immune checkpoint blockade (ICB; anti-PD-1/anti-CTLA-4) correlate with the extent of tumor immune infil..

University of Melbourne Researchers

Paul Beavis's Profile Picture
Paul Beavis The Sir Peter Maccallum Department of Oncology

Phillip Darcy's Profile Picture
Phillip Darcy The Sir Peter Maccallum Department of Oncology

Sherene Loi's Profile Picture
Sherene Loi The Sir Peter Maccallum Department of Oncology

Jane Oliaro's Profile Picture
Jane Oliaro The Sir Peter Maccallum Department of Oncology
  • «
  • ‹

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  ›

About us  

›

Careers at Melbourne  

›

Safety and respect  

›

Newsroom  

›

Contact  

›

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  ›
facebookIcontwitterIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224